Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Relenopride by SK Life Science for Unspecified Neurologic Disorders: Likelihood of Approval
Relenopride is under clinical development by SK Life Science and currently in Phase I for Unspecified Neurologic Disorders. According to...
Data Insights
Cenobamate by SK Life Science for Liver Failure (Hepatic Insufficiency): Likelihood of Approval
Cenobamate is under clinical development by SK Life Science and currently in Phase I for Liver Failure (Hepatic Insufficiency). According...